Sarah Cheney
Areas of Focus
Overview
Sarah Cheney supports Crowell Health Solutions, a strategic consulting firm affiliated with Crowell & Moring, to help clients pursue and deliver innovative alternatives to the traditional approaches of providing and paying for health care, including through digital health, health equity, and value-based health care. She is a healthcare policy intern in the Washington, D.C. office.
Sarah's Insights
Client Alert | 2 min read | 08.04.25
On Monday, July 21, 2025, the Food and Drug Administration (FDA) issued draft guidance entitled “E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials” from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance is currently in Step 2 of the ICH process and open for public comment until September 19, 2025.
Insights
The Role of Federal and State Governments in Maintaining Healthcare During Natural Disasters
|05.07.25
Crowell Health Solution’s Trends in Transformation
AMA’s CPT Editorial Panel Approves New Codes Covering Remote Patient Monitoring Services
|01.15.25
Crowell Health Solution’s Trends in Transformation
HHS Releases Final Guidance for the Second Cycle of the Medicare Drug Price Negotiation Program
|11.14.24
Crowell Health Solution’s Trends in Transformation
Practices
Sarah's Insights
Client Alert | 2 min read | 08.04.25
On Monday, July 21, 2025, the Food and Drug Administration (FDA) issued draft guidance entitled “E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials” from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance is currently in Step 2 of the ICH process and open for public comment until September 19, 2025.